Format

Send to

Choose Destination
Curr Opin Anaesthesiol. 2008 Aug;21(4):467-72. doi: 10.1097/ACO.0b013e3283007eb4.

Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgery.

Author information

1
Department of Anesthesiology, Tulane University Medical Center, New Orleans, Louisiana 70112, USA. charles.fox@hcahealthcare.com

Abstract

PURPOSE OF REVIEW:

Pulmonary hypertension is a condition that has a multitude of causes. Left untreated, patients with pulmonary hypertension will experience progressive symptoms of dyspnea and right heart failure resulting in significant morbidity and mortality. This review details the many evolving aspects of understanding related to pulmonary hypertension including signs and symptoms, pathophysiology, classification, anesthetic management including perioperative considerations and treatment options.

RECENT FINDINGS:

Relatively new pharmacological agents developed through translatable animal research over the past few decades have broadened the therapeutic options for clinicians attempting to manage the difficult symptoms related to pulmonary hypertension. Currently available drugs utilized in the management of these complex patients are discussed in this review.

SUMMARY:

Coupled with aggressive use of improved diagnostic hemodynamic monitors perioperatively, these patients can be medically optimized during their hospitalization and possibly aid in improving their long-term prognosis.

PMID:
18660654
DOI:
10.1097/ACO.0b013e3283007eb4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center